Dynavax Technologies | Markedsværdi



Market Capitalization Lave om Dato
AbbVie USD 314.02B 34.8B 2024-12
Adma Biologics USD 4.66B 2.07B 2024-09
Amgen USD 140.1B 33.03B 2024-12
AstraZeneca GBP 162.31B 17.34B 2024-12
Biogen USD 22.28B 5.95B 2024-12
BioMarin Pharmaceutical USD 12.53B 867M 2024-12
Bristol-Myers Squibb USD 114.71B 9.82B 2024-12
Dynavax Technologies USD 1.68B 219M 2024-12
Gilead Sciences USD 115.12B 10.74B 2024-12
Glaxosmithkline USD 82.81B 2.66B 2024-09
Merck USD 251.65B 36.21B 2024-12
Neurocrine Biosciences USD 13.82B 2.18B 2024-12
Novartis CHF 194.25B 18.5B 2024-12
Pfizer USD 150.34B 13.65B 2024-12
Regeneron Pharmaceuticals USD 78.28B 37.61B 2024-12
TG Therapeutics USD 3.62B 871M 2024-09
Vertex Pharmaceuticals USD 103.71B 16.33B 2024-12



Dynavax Technologies Markedsværdi - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.